ClinicalTrials.gg
CompletedNCT01835652PETUpdated Mar 17, 2021

The Effects of Exercise in Parkinson's Disease

An interventional study of Active Exercise and Passive Exercise in Parkinson Disease 10, sponsored by Pacific Parkinson's Research Centre. Completed at 1 site in Canada. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-03-17.

Primary conditionParkinson DiseaseRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Parkinson Disease
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Parkinson Disease.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Pacific Parkinson's Research Centre · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 253 studies in Parkinson Disease with a site in Canada — 43 open to participants now, 62 under way, 3 of them phase 3. Parkinson Disease · Canada.

Enrollment
177th of 212
18 · median 60
Started
2013
with 9 others
No phase
95 of 253
24 open now
Registered
70th of 253
by date
Lead sponsor
7 of 253
Pacific Parkinson's Research Centre

Among the 253 studies in Parkinson Disease with a site in Canada, this one is the 177th largest by enrollment of the 212 interventional ones that give a count, is one of 10 that started in 2013, is one of 95 with no phase, and was the 70th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

43 of the 253 studies in Parkinson Disease with a site in Canada are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 40 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 253 studies in Parkinson Disease with a site in Canada, or all of them as a file.
02

Study summary

Parkinson's disease is caused by a reduction of dopamine causing motor deficits. The investigators are studying how exercise can help PD patients by increasing dopamine release in an area of the brain that coordinates movement, the striatum. The investigators will enroll PD patients into two groups; one group will complete a 12-week aerobic exercise program and the other will complete a 12-week control program including yoga and stretching only. The investigators will measure changes in dopamine release before and after either 12-week intervention. Subjects will complete motor and cognitive questionnaires in addition to functional magnetic resonance imaging and positron emission tomography neuroimaging.

Read the detailed description

The purpose of this study is to determine the basis for symptomatic and disease modifying benefits of exercise in Parkinson's disease (PD).

Although the benefits of exercise in PD have been purported for several decades, only recently have there been controlled reports of symptomatic benefits in Parkinson's disease in terms of bradykinesia, postural balance and quality of life. There have been unsubstantiated suggestions that exercise may improve cognition and mood in PD.

The mechanisms underlying such benefits are poorly understood. Exercise may induce dopamine release, thereby contributing to improved motor function in the dorsal striatum, and to enhanced mood and reduced apathy in the ventral striatum.

We will test the hypotheses that exercise results in altered synaptic plasticity in the form of altered connectivity in response to aerobic exercise and reward-induced dopamine release. We will assess networks of functional connectivity using functional magnetic resonance imaging and measure dopamine release with positron emission tomography (PET).

03

Conditions studied

  • Parkinson Disease 10

Browse trials for

Keywords

  • Exercise
  • Parkinson's Disease
  • Positron Emission Tomography
  • fMRI
04

In context

Parkinson Disease Reclassified

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

This study's enrollment of 18 is below the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Pacific Parkinson's Research Centre is the lead sponsor of 7 studies on the registry; none are open to participants now.

Compared within Parkinson Disease, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Idiopathic PD according to UK Brain Bank criteria (modified to permit inclusion of subjects with a family history)
  2. Ages 40-70
  3. Mild to moderate Parkinsonism (Hoehn \& Yahr stages I-III)

Exclusion criteria

Exclusion Criteria:

General exclusion criteria will include:

  1. more than 120 minutes per week of activities >3 MET or a score exceeding 4 on the "Baseline Exercise Screening Tool" (Appendix, Fig. 1);
  2. atypical Parkinson syndrome (progressive supranuclear palsy, multiple system atrophy, drug-induced etc.);
  3. significant osteoporosis or arthritis;
  4. other neurological disease (e.g. myopathy);
  5. self-reports claustrophobia;
  6. history of cancer within 5 years of study participation;
  7. high dose of radiation from other procedures within the year;
  8. taking rasagiline or selegiline for PD therapy;
  9. diabetic;
  10. not able to tolerate being off PD medication for up to 24 hours;
  11. of 35 or more; and
  12. a female subject who is breast-feeding or pregnant.

Exclusion criteria for MRI scanning and magnetic stimulation from rTMS scanning includes:

  1. artificial heart valve;
  2. brain aneurysm clip;
  3. electrical stimulator for nerves or bones;
  4. ear or eye implant;
  5. implanted drug infusion pump;
  6. coil, catheter, or filter in any blood vessel;
  7. orthopedic hardware (artificial joint, plate, screws);
  8. other metallic prostheses;
  9. shrapnel, bullets, or other metal fragments;
  10. surgery or tattoos (including tattooed eyeliner) in the last six weeks;
  11. have a cardiac pacemaker, wires or defibrillator;
  12. have had an injury where a piece of metal lodged in your eye or orbit;
  13. have a ferromagnetic aneurysm clip; and
  14. have a history of seizures.

Subjects may be excluded following study enrollment if they meet any of the following exclusion criteria:

  1. significant cognitive impairment ( score \< 24) or depression (Beck Depression Inventory score > 18);
  2. significant or unstable cardiovascular or respiratory disease - all subjects will undergo a screening exercise bicycle stress test; or
  3. failure to comply with the exercise or yoga/stretching intervention program, including missing 5 sessions or missing three sessions in a row.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

06

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
18 participants (actual)

Study arms

  • Active comparator
    Active Exercise

    Aerobic Exercise Intervention (stationary cycling)

    Other: Active Exercise

  • Other
    Passive Exercise

    Passive Exercise (stretching and balance based exercise)

    Other: Passive Exercise

Interventions

  • OtherActive Exercise
  • OtherPassive Exercise
07

What researchers measure

Primary outcomes

  1. PET

    Dopamine release will be assessed using positron emission tomography (PET)

    Time frame: 3 months

Secondary outcomes

  1. fMRI

    fMRI will be performed to record response to rewarding stimuli

    Time frame: 3 months

Other outcomes

  1. Clinical Measures

    Motor function will be assessed using the MDS-Unified Parkinson's Disease Rating Scale, finger tapping and Purdue Pegboard. Cognitive function will be assessed using the Montreal Cognitive Assessment, Wisconsin Card-Sorting Task, Trail-Making B Test and a computerized reaction time test. Mood and apathy will be assessed using the Beck Depression Inventory and Starkstein Apathy Scale.

    Time frame: 3 months

08

Study locations

1 site
  • Pacific Parkinson's Research Centre
    Vancouver, British Columbia V6T 2B5, Canada
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2013, a primary completion of Mar 2015 and a completion of Mar 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2013
First posted
Apr 19, 2013
Start
Apr 2013
Primary completionActual
Mar 2015
CompletionActual
Mar 2015
Last update
Mar 17, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01835652
Lead sponsor
Pacific Parkinson's Research Centre
Responsible party
A. Jon Stoessl (Director, Pacific Parkinson's Research Centre, Pacific Parkinson's Research Centre) — Principal investigator
First posted
Apr 19, 2013
Start date
Apr 2013
Primary completion
Mar 2015
Completion
Mar 2015
Last update
Mar 17, 2021

Study contacts

Jessamyn McKenzie
study director · Pacific Parkinson's Research Centre

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion